TCIM
SYRS
TIAA CREF Investment Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $363K | Sell |
39,754
-16
| -0% | -$146 | ﹤0.01% | 2717 |
|
|
2018
Q4 | $222K | Sell |
39,770
-810
| -2% | -$4.52K | ﹤0.01% | 2854 |
|
|
2018
Q3 | $483K | Sell |
40,580
-23,281
| -36% | -$277K | ﹤0.01% | 2730 |
|
|
2018
Q2 | $652K | Buy |
63,861
+24,704
| +63% | +$252K | ﹤0.01% | 2661 |
|
|
2018
Q1 | $508K | Buy |
39,157
+8,687
| +29% | +$113K | ﹤0.01% | 2727 |
|
|
2017
Q4 | $296K | Sell |
30,470
-1,524
| -5% | -$14.8K | ﹤0.01% | 2945 |
|
|
2017
Q3 | $471K | Sell |
31,994
-2,396
| -7% | -$35.3K | ﹤0.01% | 2851 |
|
|
2017
Q2 | $553K | Buy |
34,390
+29,782
| +646% | +$479K | ﹤0.01% | 2818 |
|
|
2017
Q1 | $73K | Hold |
4,608
| – | – | ﹤0.01% | 3057 |
|
|
2016
Q4 | $56K | Buy |
+4,608
| New | +$56K | ﹤0.01% | 3102 |
|